slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 91,831-91,860
Pages 3,683
Rows per page 30
Component
91,831-91,860 of 110,471
14
The slide outlines the three pillars of the company's regulatory structure: BDC, RIC, and SBIC.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
16
The slide uses a consistent layout of green name/title blocks paired with bulleted professional history.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
17
The chart highlights specific periods like the 'Recessionary Period' and 'COVID Pandemic Period' to demonstrate dividend stability.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
21
The chart uses a 3D pie representation to show a highly fragmented portfolio with no single industry dominating.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
29
Includes detailed footnotes explaining calculation methodologies for yield and interest rates.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
30
Includes detailed footnotes regarding calculation methodology for yields and interest rates.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
31
The chart displays 26 distinct industry segments with percentages ranging from 1% to 13%.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
43
The chart displays debt maturity by year, categorized by instrument type (SBIC debentures, Credit Facilities, and various Notes).Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
44
The table shows a clear asymmetric impact due to interest rate floors on the investment side.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
47
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
49
Main Street Capital | Investor Presentation Deck | 49 slidesMain Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
06
Includes a process diagram for the test workflow and product imagery.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
07
The slide outlines the technical workflow from sample collection (FIT tube and DNA stabilization tube) through analysis to the final patient report.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
Uses data from Ladabaum U, et al. (JNCI, 2022) to justify the importance of AA detection thresholds.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
16
The slide uses a process flow diagram to explain the technical methodology of the screening test.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
03
The slide uses a process-flow structure to connect the technology platform (LNCs) to a lead asset (MAT2203) and future pipeline expansion.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
06
Technical scientific slide detailing the mechanism of action for a drug delivery platform.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Product1 hit
11
The slide uses a process flow diagram to map clinical outcomes to specific data points.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a process flow diagram to illustrate the clinical trial methodology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
Data presented as a multi-panel chart comparing Uninfected, Infected Untreated, SQ Remdesivir, and Oral LNC-Remdesivir groups.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
24
The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
The chart shows a clear dose-response relationship with increasing efficacy of the LNC formulation at 2.5, 5, and 10 nM doses.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
30
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Team1 hit
12
The slide combines a service portfolio description with a dual-axis combo chart showing financial performance.Matson | Investor Presentation Deck | 14 slides · Matson
Pitch deck Investor relations Beat · Business Model1 hit
04
The slide uses a timeline framework to establish company history and credibility.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Problem1 hit
05
Uses a before-after framing to position the platform as a solution to industry-wide pain points.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
MaxCyte | Results Presentation Deck | 25 slidesMaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses donut charts to show the shift in milestone distribution across IND, Pre-Pivotal, and Pivotal or Later phases.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit